A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis

Hepato-Gastroenterology

Volumn 59, Issue 120, 2012, Pages 2592-2597

  Cheong, Jae Youn ^a   Um, Soon Ho ^b   Seo, Yeon Seok ^b   Shin, Seung Soo ^a   Park, Rae Woong ^a   Kim, Dong Joon ^c   Hwang, Seong Gyu ^d   Lee, Youn Jae ^e   Cho, Mong ^f   Yang, Jin Mo ^g   Kim, Young Bae ^a   Park, Young Nyun ^h   Cho, Sung Won ^a  

^a Ajou University School of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Hallym University College of Medicine   (South Korea)

^d CHA University   (South Korea)

^e Inje University College of Medicine   (South Korea)

^f Pusan National University School of Medicine   (South Korea)

^g The Catholic University of Korea College of Medicine   (South Korea)

^h Yonsei University College of Medicine   (South Korea)

Author keywords

Chronic hepatitis; Decision tree algorithm; Hyaluronic acid; Liver fibrosis; Procollagen iii N terminal peptide

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA 2 MACROGLOBULIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GELATINASE A; HYALURONIC ACID; NITROGEN; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CREATININE BLOOD LEVEL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL;

ADULT; ALGORITHMS; BIOLOGICAL MARKERS; BIOPSY; CHI-SQUARE DISTRIBUTION; DECISION SUPPORT TECHNIQUES; DECISION TREES; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; HYALURONIC ACID; LIKELIHOOD FUNCTIONS; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDE FRAGMENTS; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROCOLLAGEN; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 84872092331     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge10157     Document Type: Article

References (27)

1. Abdi W, Millan JC, Mezey E: Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979; 139:667-669.
2. Bedossa P, Dargere D, Paradis V: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38:1449-1457.
3. Rousselet MC, Michalak S, Dupre F, et al.: Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005; 41:257-264.
4. Afdhal NH, Nunes D: Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004; 99:1160-1174.
5. Adams LA, Bulsara M, Rossi E, et al.: Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005; 51:1867-1873.
6. Cales P, Oberti F, Michalak S, et al.: A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005; 42:1373-1381.
7. Forns X, Ampurdanes S, Llovet JM, et al.: Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36:986-992.
8. Imbert-Bismut F, Ratziu V, Pieroni L, et al.: Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357:1069-1075.
9. Lok AS, Ghany MG, Goodman ZD, et al.: Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort Hepatology 2005; 42:282-292.
10. Myers RP, Tainturier MH, Ratziu V, et al.: Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 2003; 39:222-230.
11. Rosenberg WM, Voelker M, Thiel R, et al.: Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004; 127:1704-1713.
12. Rossi E, Adams L, Prins A, et al.: Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem 2003; 49:450-454.
13. Wai CT, Greenson JK, Fontana RJ, et al.: A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518-526.
14. Zeng MD, Lu LG, Mao YM, et al.: Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a non-invasive model. Hepatology 2005; 42:1437-1445.
15. Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J: Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology 2003; 38:481-492.
16. Le Calvez S, Thabut D, Messous D, et al.: The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C. Hepatology 2004; 39:862-863 (author reply 863).
17. Thabut D, Simon M, Myers RP, et al.: Non-invasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology 2003; 37:1220-1221 (author reply 1221).
18. Podgorelec V, Kokol P, Stiglic B, Rozman I: Decision trees: an overview and their use in medicine. J Med Syst 2002; 26:445-463.
19. Bravo AA, Sheth SG, Chopra S: Liver biopsy. N Engl J Med 2001; 344:495-500.
20. Bedossa P, Poynard T: An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24:289-293.
21. Quinlan J: Programs for machine learning: Morgan Kaufmann Publishers; 1993.
22. Poynard T, Munteanu M, Imbert-Bismut F, et al.: Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004; 50:1344-1355.
23. McGary CT, Raja RH, Weigel PH: Endocytosis of hyaluronic acid by rat liver endothelial cells. Evidence for receptor recycling. Biochem J 1989; 257:875-884.
24. Guechot J, Laudat A, Loria A, et al.: Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 1996; 42:558-563.
25. Gressner AM, Bachem MG: Cellular sources of non-collagenous matrix proteins: role of fat-storing cells in fibrogenesis. Semin Liver Dis 1990; 10:30-46.
26. McHutchison JG, Blatt LM, de Medina M, et al.: Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol 2000; 15:945-951.
27. Gebo KA, Herlong HF, Torbenson MS, et al.: Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 2002; 36:S161-172.